Detalles de la búsqueda
1.
Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
J Pathol
; 261(2): 156-168, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37555303
2.
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.
Int J Mol Sci
; 23(20)2022 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36293165
3.
Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.
Cancer Control
; 28: 10732748211047117, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34565216
4.
Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report.
BMC Infect Dis
; 21(1): 1148, 2021 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758746
5.
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Int J Cancer
; 144(7): 1713-1722, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30192385
6.
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
Br J Cancer
; 121(8): 690-698, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527689
7.
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.
PLoS Genet
; 8(2): e1002532, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22383897
8.
Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.
Hum Mol Genet
; 20(24): 4991-9, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21908515
9.
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
PLoS Genet
; 6(6): e1001002, 2010 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20585626
10.
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer.
Cancers (Basel)
; 15(8)2023 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190199
11.
Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment.
Int J Infect Dis
; 132: 40-49, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072051
12.
SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes.
Cancers (Basel)
; 14(13)2022 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35805058
13.
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Cancers (Basel)
; 14(8)2022 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35454830
14.
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Oral Oncol
; 126: 105736, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121396
15.
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
Oral Oncol
; 114: 105158, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508707
16.
The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis.
Front Oncol
; 11: 626145, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33718193
17.
Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer.
Clin Transl Med
; 11(11): e578, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34841695
18.
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Front Oncol
; 10: 1417, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974150
19.
Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population.
World J Gastrointest Oncol
; 11(11): 1031-1042, 2019 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31798783
20.
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
Medicine (Baltimore)
; 96(15): e6518, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28403082